MSN Laboratories Pvt. Ltd – Walk-In Interview for TSD & SRD Departments | Hyderabad
About the Opportunity
MSN Laboratories Pvt. Ltd is conducting a walk-in interview for positions in the TSD and SRD departments. This opportunity is open to candidates with qualifications such as B.Tech, M.Tech and M.Sc, with zero to six years of experience. The recruitment process will be conducted face-to-face and will include an HR interview round. Interested and eligible candidates are encouraged to attend the interview at the scheduled date and venue.
Vacancy Information
Openings are available in the TSD and SRD departments. Candidates with relevant educational backgrounds and experience ranging from freshers to six years are eligible to apply. MSN Laboratories is particularly interested in candidates with experience in QA OSD functions including IPQA, AQA, packing, documentation and validations.
Role and Responsibilities
The roles involve supporting documentation, research and development activities associated with technical service and scientific research functions. Candidates are expected to have a strong understanding of pharmaceutical processes, quality systems and regulatory guidelines. Additional responsibilities may be discussed during the interview based on the department’s needs.
Walk-In Interview Details
The walk-in interview will be held on 19th December 2025.
The interview timing is from 9:00 AM to 4:00 PM.
The venue is MSN Laboratories Pvt. Ltd, R&D Center, Pashamylaram, Hyderabad.
Documents to Bring
Candidates must bring their updated resume, photocopies of educational certificates, passport-size photographs and a copy of their Aadhaar card. Additional documents required include the latest increment letter, pay slips, bank statements, Aadhaar card and PAN card for verification.
About MSN Group
MSN Group is one of India’s fastest-growing research-based pharmaceutical companies. Established in 2003 with a mission to make healthcare affordable, MSN has built a strong global presence with fifteen API and six finished dosage facilities across India and the USA. The company operates an integrated R&D center focusing on the development of both APIs and formulations.
MSN holds more than 900 national and international patents and offers a rich product portfolio of over 450 APIs and more than 300 formulations across 35 therapeutic categories. Serving over 40 million patients in more than 80 countries, MSN continues to grow by focusing on innovation, speed and quality, supported by a dedicated team of more than 14,000 professionals.
